Browse
Topics & Collections
Search for a specific
disease or term
—  or  —
Learn more about ACP Smart Medicine

Dynamed

X
This content was provided by DynaMed (dynamed.ebscohost.com). For more information click here.
Last Updated: 1/4/2012  

Hepatitis A

DOI: 10.7326/d471
The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP.
Disclosures:
Catherine M. Dentinger, FNP, MPH Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene
New York, NY
has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Brian J. McMahon, MD, MACP Viral Hepatitis Program at the Alaska Native Tribal Health Consortium; Centers for Disease Control and Prevention/Arctic Investigations Program
Anchorage, AK
Spouse has 100 shares of GSK in her IRA; GSK makes Hepatitis A vaccine.
Catherine M. Dentinger, FNP, MPH Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene
New York, NY
has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Brian J. McMahon, MD, MACP Viral Hepatitis Program at the Alaska Native Tribal Health Consortium; Centers for Disease Control and Prevention/Arctic Investigations Program
Anchorage, AK
Spouse has 100 shares of GSK in her IRA; GSK makes Hepatitis A vaccine.
Deborah Korenstein, MD, FACP, Editor in Chief, ACP Smart Medicine, has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Richard B. Lynn, MD, FACP, Editor, ACP Smart Medicine, has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Related Content
Annals of Internal Medicine